Keyphrases
3,4-methylenedioxymethamphetamine
35%
4F-MDMB-BINACA
13%
Abuse Liability
16%
AD Mice
13%
Adult Mice
26%
Age-associated
21%
Age-related Cognitive Impairment
14%
Aging
35%
Alzheimer's Disease
17%
Amphetamine
30%
Behavioral Effects
35%
Behavioral Pharmacology
28%
Benzylpiperazine
13%
Cocaine
64%
Coenzyme Q10
40%
Cognitive Decline
14%
Cognitive Function
47%
Conditioned Place Preference
48%
CUMYL
13%
Discriminative Stimulus Effects
76%
Drug Discrimination
35%
ED50
61%
Experimental Ischemic Stroke
13%
Fibroblast Reprogramming
13%
Functional Impairment
14%
Hippocampus
15%
Impure
13%
Locomotor
61%
Locomotor Activity
28%
Low Protein
13%
Methamphetamine
100%
Methylenedioxypyrovalerone
13%
Neurobehavior
14%
Nonhuman Animals
13%
Pavlovian Conditioning
13%
Photoreceptor
13%
Place Preference
15%
Place Preference Conditioning
13%
Protein Oxidation
14%
Psychostimulants
51%
Rodent Behavior
13%
Rodents
57%
Self-administration
14%
Spatial Learning
20%
Stimulants
33%
Stroke Model
13%
Swiss Albino Mice
17%
Synthetic Cathinones
26%
Transient Middle Cerebral Artery Occlusion (tMCAO)
21%
Vascular Dementia
29%
Neuroscience
Adenosine Triphosphate
8%
Alzheimer's Disease
31%
Amphetamine
16%
Analeptic
26%
Associative Memory
6%
Astrogliosis
6%
Aversion
13%
Behavior (Neuroscience)
36%
Brain Ischemia
17%
Brain Metabolism
13%
Brain Region
10%
C57BL 6 Mouse
11%
Cathinone
13%
Cerebellum
13%
Cerebrovascular Accident
10%
Cerebrum
6%
Classical Conditioning
13%
Coenzyme
40%
Cognitive Disorders
17%
Cognitive Function
44%
Conditioned Place Preference
53%
Creatine Kinase
13%
Dietary Supplement
9%
Drug Discrimination
26%
Excitotoxicity
13%
Fibroblast
13%
Hallucinogen
13%
Hippocampus
17%
Immunohistochemistry
7%
Intraperitoneal Injection
10%
Locomotor Activity
12%
Long-Term Potentiation
10%
Metabolic Pathway
6%
Metformin
13%
Methionine Synthase
13%
Methylenedioxypyrovalerone
13%
Middle Cerebral Artery
21%
Neurodegeneration
15%
Neurotoxicity
10%
Oxidative Stress
13%
Photoreceptor
13%
Plaque
8%
Psychostimulant
45%
Purkinje Cell
13%
Reprogramming
13%
Stereotypic Movement Disorder
6%
Striatum
10%
Synaptic Transmission
5%
Vascular Dementia
29%
Pharmacology, Toxicology and Pharmaceutical Science
2,5 Dimethoxy 4 Methylamphetamine
34%
Alzheimer's Disease
13%
Amphetamine
13%
Astrocytosis
6%
Behavioral Effect
35%
Behavioral Pharmacology
30%
Benzimidazole
6%
Benzofuran
13%
Benzylpiperazine
13%
C57BL 6 Mouse
10%
Cannabinoid
13%
Cathinone
40%
Dexamphetamine
13%
Drug Dependence
13%
Drug Market
8%
Duragesic
10%
Etonitazene
13%
Excitotoxicity
13%
Hallucinogen
15%
Intraperitoneal Injection
13%
Long Term Exposure
10%
MDMA
27%
Meta-Chlorophenylpiperazine
8%
Methionine Synthase
13%
Methylenedioxypyrovalerone
13%
Morphine
10%
Motor Dysfunction
6%
Multiinfarct Dementia
13%
Naltrexone
6%
Nerve Degeneration
13%
Neurotoxicity
10%
Piperazine
5%
Preference
45%
Psychostimulant
68%
Sprague Dawley Rat
13%
Subjective Effects
5%
Swiss Webster Mouse
19%
Table Salt
14%
Tetrahydrocannabinol
10%
Tryptamine
13%